AT378364T
Polyanhydrides with therapeutically useful degradation products
Abstract
A having constitutional repeating unit (I) is a anhydride, wherein Ar is an aromatic ring of the substituted or un-substituted, comprising the anhydride groups and structure thereof is a functional group on each Ar substituted. Further comprises an aromatic dicarboxylic acid anhydride monomer and a ortho-substituted and an aromatic dicarboxylic acid for intermediate claimed is ortho-substituted, and other is anhydride can embedded a medical device, r3 is a completely reconstitution to the frame, drug release system; The oral form a method of treatment used.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
111 members in 15 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 5832897 | United States of America | P |
Members111
| Document | Office | Kind | |
|---|---|---|---|
| CA2302508A1 | Canada | A1 | |
| WO9912990A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU9311798A | Australia | A | |
| EP1032605A1 | European Patent Office (EPO) | A1 | |
| CN1269811A | China | A | |
| KR20010023852A | Republic of Korea | A | |
| CA2387558A1 | Canada | A1 | |
| WO0128492A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7877100A | Australia | A | |
| WO0128492A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2001515934A | Japan | A | |
| US6304653B1 | United States of America | B1 | |
| CA2417388A1 | Canada | A1 | |
| CA2417389A1 | Canada | A1 | |
| CA2771263A1 | Canada | A1 | |
| WO0209767A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0209768A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7805201A | Australia | A | |
| AU7805501A | Australia | A | |
| EP1032605A4 | European Patent Office (EPO) | A4 | |
| US2002031212A1 | United States of America | A1 | |
| US2002071822A1 | United States of America | A1 | |
| US6408065B1 | United States of America | B1 | |
| AU750424B2 | Australia | B2 | |
| US2002098161A1 | United States of America | A1 | |
| EP1246627A2 | European Patent Office (EPO) | A2 | |
| US6468519B1 | United States of America | B1 | |
| WO0209767A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0209768A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6486214B1 | United States of America | B1 | |
| MXPA02003890A | Mexico | A | |
| US2003035787A1 | United States of America | A1 | |
| JP2003511550A | Japan | A | |
| US2003059469A1 | United States of America | A1 | |
| EP1246627A4 | European Patent Office (EPO) | A4 | |
| EP1307233A2 | European Patent Office (EPO) | A2 | |
| EP1309354A2 | European Patent Office (EPO) | A2 | |
| AU750424C | Australia | C | |
| US6613807B2 | United States of America | B2 | |
| US6689350B2 | United States of America | B2 | |
| JP2004505062A | Japan | A | |
| JP2004505063A | Japan | A | |
| MXPA03000821A | Mexico | A | |
| MXPA03000820A | Mexico | A | |
| CA2506319A1 | Canada | A1 | |
| WO2004045549A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003295635A1 | Australia | A1 | |
| CN1158325C | China | C | |
| EP1464673A2 | European Patent Office (EPO) | A2 | |
| WO2004045549A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005031577A1 | United States of America | A1 | |
| US2005053577A1 | United States of America | A1 | |
| US2005089506A1 | United States of America | A1 | |
| KR20050086736A | Republic of Korea | A | |
| EP1572154A2 | European Patent Office (EPO) | A2 | |
| EP1246627B1 | European Patent Office (EPO) | B1 | |
| AU2005242165A1 | Australia | A1 | |
| AT314078T | Austria | T | |
| ATE314078T1 | Austria | T1 | |
| DE60025272D1 | Germany | D1 | |
| CN1735404A | China | A | |
| JP2006506191A | Japan | A | |
| AU2001278052B2 | Australia | B2 | |
| US2006188546A1 | United States of America | A1 | |
| US7122615B1 | United States of America | B1 | |
| US2007196417A1 | United States of America | A1 | |
| US2007213500A1 | United States of America | A1 | |
| EP1032605B1 | European Patent Office (EPO) | B1 | |
| AT378364TThis record | Austria | T | |
| ATE378364T1 | Austria | T1 | |
| PT1032605E | Portugal | E | |
| EP1464673A3 | European Patent Office (EPO) | A3 | |
| DE69838731D1 | Germany | D1 | |
| DK1032605T3 | Denmark | T3 | |
| DE69838731T2 | Germany | T2 | |
| EP1572154A4 | European Patent Office (EPO) | A4 | |
| ES2296344T3 | Spain | T3 | |
| JP2008150367A | Japan | A | |
| JP4130305B2 | Japan | B2 | |
| US2008226583A1 | United States of America | A1 | |
| US2008233078A1 | United States of America | A1 | |
| US7534852B2 | United States of America | B2 | |
| US7666398B2 | United States of America | B2 | |
| US2010074937A1 | United States of America | A1 | |
| EP1307233B1 | European Patent Office (EPO) | B1 | |
| AT471160T | Austria | T | |
| ATE471160T1 | Austria | T1 | |
| DE60142396D1 | Germany | D1 | |
| EP2233155A2 | European Patent Office (EPO) | A2 | |
| EP2233155A3 | European Patent Office (EPO) | A3 | |
| EP2277549A2 | European Patent Office (EPO) | A2 | |
| CA2302508C | Canada | C | |
| EP2277549A3 | European Patent Office (EPO) | A3 | |
| CA2417388C | Canada | C | |
| US7985415B2 | United States of America | B2 | |
| US8017714B2 | United States of America | B2 | |
| EP1572154B1 | European Patent Office (EPO) | B1 | |
| AT543488T | Austria | T | |
| ATE543488T1 | Austria | T1 | |
| ES2377827T3 | Spain | T3 |
Showing 100 of 111
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 98946004
Titles2
- German
- POLYAMHYDRIDE MIT THERAPEUTISCH VERWENDBAREN ABBAUPRODUKTEN
- English
- POLYAMIDE DRIDS USING THERAPEUTICALLY APPLICABLE DERIVED PRODUCTS
Classification
- CPC, 4
- C08G67/04
- A61K9/2031
- A61L27/18
- A61P1/00
- IPC, 7
- A61K9 20
- A61L27 18
- C08G63 00
- C08G63 02
- C08G67 00
- C08G67 04
- C08G69 00